Edge Pharma, LLC recalls Mitomycin-C, 40mg/40mL (1mg/mL), 40 mL per syringe, Single Dose Syringe for Intravesical Use, Edge Pharma, LLC, 856 Herc
Recalled February 2, 2022 · FDA recall D-0407-2022 · Edge Pharma
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
860 syringes
Sold at
nationwide
Description
Lack of Assurance of Sterility
Product
Mitomycin-C, 40mg/40mL (1mg/mL), 40 mL per syringe, Single Dose Syringe for Intravesical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1416-01
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →